Science & Enterprise subscription

Follow us on Twitter

  • Our #podcast is now live ... NPC Members Display Photos At Annual Club Exhibit https://t.co/EsClVw9ZNc @pressclubdc #NPCPhotoEx
    about 1 day ago
  • More Democrats say they're in favor of increased federal spending on scientific research than Republicans, a gap th… https://t.co/SQBna2FykD
    about 1 day ago
  • New post on Science and Enterprise: Infographic – Partisan Split Remains on Research Spending https://t.co/FabPa5ufSb #Science #Business
    about 1 day ago
  • The first participant in a clinical trial received an experimental minimally-invasive brain implant to record brain… https://t.co/nPUNY6S2a5
    about 2 days ago
  • New post on Science and Enterprise: Trial Underway Testing Brain-Computer Implant https://t.co/olPDnbtfnW #Science #Business
    about 2 days ago

Please share Science & Enterprise

Opioid Abuse Treatment Medications Underused

Head in hands

While three medications for opioid abuse are approved by the Food and Drug Administration, the treatments are used sparingly in therapy according to a new review of data. . . . → Read More: Opioid Abuse Treatment Medications Underused

NIH Funds Augmented-Reality Endovascular System

Heart, circulation system

A grant from National Institutes of Health is funding a system using augmented reality and holography to improve minimally-invasive repair of blood vessels. . . . → Read More: NIH Funds Augmented-Reality Endovascular System

Companies Call for Genome Editing Regulations

Crispr genome edits illustration

A group of companies developing treatments for disease using genome editing are calling for regulations and standards to govern these technologies in regenerative medicine. . . . → Read More: Companies Call for Genome Editing Regulations

FDA Okays Celiac Disease Engineered Microbe Trial

fresh bread

A company making synthetic biological therapies received authorization to begin clinical trials in the U.S. for an engineered microbe to treat celiac disease. . . . → Read More: FDA Okays Celiac Disease Engineered Microbe Trial

FDA Investigating Data Manipulation in Gene Therapy Approval

Magnify facts

The Food and Drug Administration is investigating manipulation of preclinical tests submitted for its approval of a gene therapy to treat a rare disease. . . . → Read More: FDA Investigating Data Manipulation in Gene Therapy Approval

Energy-Efficient Process Devised for Nano-Emulsions

Water drops

A more efficient process using less energy is being developed for producing emulsions with tiny droplets to deliver drugs or cosmetics through the skin. . . . → Read More: Energy-Efficient Process Devised for Nano-Emulsions

Synthetic Cannabidiol Shown to Reduce Seizures

Epilepsy graphic

A synthetic form of cannabidiol, or CBD, a derivative of cannabis, is shown in tests with lab rats to reduce the occurrence of seizures from epilepsy. . . . → Read More: Synthetic Cannabidiol Shown to Reduce Seizures

FDA Clears Wearable App Device for Migraine

Nerivio Migra patch

The Food and Drug Administration authorized a wearable nerve-stimulation device controlled by a mobile app to treat acute migraine headaches. . . . → Read More: FDA Clears Wearable App Device for Migraine

FDA Approves Rare Infant Disease Gene Therapy

Neurons

The Food and Drug Administration today approved a treatment for spinal muscular atrophy in young children that replaces a faulty gene in motor neurons with a healthy one. . . . → Read More: FDA Approves Rare Infant Disease Gene Therapy

Trial Shows Surgical Pain Managed Without Opioids

Head in hands

Results from a clinical trial show patients recovered from their hernia surgeries with non-opioid pain medications, and stayed off opioids for 15 days. . . . → Read More: Trial Shows Surgical Pain Managed Without Opioids